NIKKEI 225
38,688.66 +452.59 (+1.18%) HANG SENG
18,446.34 -131.96 (-0.71%) CRUDE OIL
78.71 +0.23 (+0.29%) GOLD FUTURES
2,329.80 -1.40 (-0.06%) DOW
38,852.27 +176.59 (+0.46%) Bitcoin GBP
50,739.36 -163.90 (-0.32%)
Minerva Surgical, Inc. (UTRS)
- GlobeNewswire
Minerva Surgical Reports Third Quarter 2023 Financial Results
SANTA CLARA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, today reported third quarter financial results for the period ended September 30, 2023. Third Quarter Highlights: Reported revenue of $12.0 million in the third quarter of 2023, compared with revenue of $12.6 million in the third quarter of 2022Increased Symphion produc
- Zacks
Minerva Surgical, Inc. (UTRS) Reports Q2 Loss, Misses Revenue Estimates
Minerva Surgical, Inc. (UTRS) delivered earnings and revenue surprises of 44.44% and 3.80%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Investors in Minerva Surgical (NASDAQ:UTRS) from a year ago are still down 86%, even after 51% gain this past week
Minerva Surgical, Inc. ( NASDAQ:UTRS ) has rebounded strongly over the last week, with the share price soaring 51%. But...
